Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Ayman M Noreddin, Walid F Elkhatib, Kenji M Cunnion & George G Zhanel. (2011) Cumulative clinical experience from over a decade of use of levofloxacin in community-acquired pneumonia: critical appraisal and role in therapy. Drug, Healthcare and Patient Safety 3, pages 59-68.
Read now
Read now
Ayman M Noreddin & Walid F Elkhatib. (2010) Levofloxacin in the treatment of community-acquired pneumonia. Expert Review of Anti-infective Therapy 8:5, pages 505-514.
Read now
Read now
Jessina C McGregor, George P Allen & David T Bearden. (2008) Levofloxacin in the treatment of complicated urinary tract infections and acute pyelonephritis. Therapeutics and Clinical Risk Management 4:5, pages 843-853.
Read now
Read now
Articles from other publishers (12)
Jesús López-Alcalde, Ricardo Rodriguez-Barrientos, Jesús Redondo-Sánchez, Javier Muñoz-Gutiérrez, José María Molero García, Carmen Rodríguez-Fernández, Julio Heras-Mosteiro, Jaime Marin-Cañada, Jose Casanova-Colominas, Amaya Azcoaga-Lorenzo, Virginia Hernandez Santiago & Manuel Gómez-García. (2018) Short-course versus long-course therapy of the same antibiotic for community-acquired pneumonia in adolescent and adult outpatients. Cochrane Database of Systematic Reviews 2018:9.
Crossref
Crossref
Paola Pansa, Yingfen Hsia, Julia Bielicki, Irja Lutsar, A. Sarah Walker, Mike Sharland & Laura Folgori. (2017) Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000–2016: A Systematic Review and Meta-Analysis. Drugs 78:2, pages 231-244.
Crossref
Crossref
Matteo Bassetti & Elda Righi. 2017. Anti-infectives and the Lung. Anti-infectives and the Lung
1
20
.
Xu Zhao, Ju-fang Wu, Qing-yu Xiu, Chen Wang, De-ping Zhang, Jian-an Huang, Can-mao Xie, Sheng-hua Sun, Xiao-ju Lv, Bin Si, Zu-ke Xiao & Ying-yuan Zhang. (2014) A randomized controlled clinical trial of levofloxacin 750 mg versus 500 mg intravenous infusion in the treatment of community-acquired pneumonia. Diagnostic Microbiology and Infectious Disease 80:2, pages 141-147.
Crossref
Crossref
K. Metzler, K. Drlica & J. M. Blondeau. (2012) Minimal inhibitory and mutant prevention concentrations of azithromycin, clarithromycin and erythromycin for clinical isolates of Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 68:3, pages 631-635.
Crossref
Crossref
Christopher R Frei, Allison M Bell, Kristi A Traugott, Terry C Jaso, Kelly R Daniels, Eric M Mortensen, Marcos I Restrepo, Christine U Oramasionwu, Andres D Ruiz, William R Mylchreest, Vanja Sikirica, Monika R Raut, Alan Fisher & Jeff R Schein. (2011) A clinical pathway for community-acquired pneumonia: an observational cohort study. BMC Infectious Diseases 11:1.
Crossref
Crossref
Jae-Hoon Song & Ki-Suck Jung. (2010) Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy. Journal of the Korean Medical Association 53:1, pages 20.
Crossref
Crossref
Gary J. Noel. (2009) A Review of Levofloxacin for the Treatment of Bacterial Infections. Clinical Medicine. Therapeutics 1, pages CMT.S28.
Crossref
Crossref
Jae-Hoon SongKi-Suck JungMoon Won KangDo Jin KimHyunjoo PaiGee Young SuhTae Sun ShimJoong Hyun AhnChul Min AhnJun Hee WooNam Yong LeeDong-Gun LeeMi Suk LeeSang Moo LeeYeong Seon LeeHyukmin LeeDoo Ryeon Chung. (2009) Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy. Tuberculosis and Respiratory Diseases 67:4, pages 281.
Crossref
Crossref
Jae-Hoon SongKi-Suck JungMoon Won KangDo Jin KimHyunjoo PaiGee Young SuhTae Sun ShimJoong Hyun AhnChul Min AhnJun Hee WooNam Yong LeeDong-Gun LeeMi Suk LeeSang Moo LeeYeong Seon LeeHyukmin LeeDoo Ryeon Chung. (2009) Treatment Guidelines for Community-acquired Pneumonia in Korea: An Evidence-based Approach to Appropriate Antimicrobial Therapy. Infection and Chemotherapy 41:3, pages 133.
Crossref
Crossref
Vanessa R Anderson & Caroline M Perry. (2008) Levofloxacin. Drugs 68:4, pages 535-565.
Crossref
Crossref
Janet Peterson, Simrati Kaul, Mohammed Khashab, Alan C. Fisher & James B. Kahn. (2008) A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis. Urology 71:1, pages 17-22.
Crossref
Crossref